<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical pathologic classification of interstitial and diffuse lung disease in childhood</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical pathologic classification of interstitial and diffuse lung disease in childhood</h1>
<div class="graphic"><div class="figure"><div class="ttl">Clinical pathologic classification of interstitial and diffuse lung disease in childhood</div><div class="cntnt"><table cellspacing="0"><colgroup width="30%"></colgroup><colgroup width="70%"></colgroup> <tbody> <tr> <td class="subtitle1">Category</td> <td class="subtitle1">Specific entities</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Disorders more prevalent in infancy</td> </tr> <tr> <td class="indent1">Developmental lung disorders</td> <td> <ul> <li>Alveolar capillary dysplasia, with and without misalignment of the pulmonary veins</li> <li>Acinar dysplasia and congenital alveolar dysplasia</li> </ul> </td> </tr> <tr> <td class="indent1">Alveolar growth abnormalities</td> <td> <ul> <li>Pulmonary hypoplasia – eg, due to oligohydramnios, congenital diaphragmatic hernia, giant omphalocele, thoracic mass lesion</li> <li>Chronic neonatal lung disease (bronchopulmonary dysplasia) – eg, due to prematurity</li> <li>Associated with congenital heart disease</li> <li>Structural changes due to chromosomal abnormalities – eg, trisomy 21</li> <li>May be a manifestation of certain single-gene disorders, including <a href="https://www.omim.org/entry/600635" target="_blank"><em>NKX2-1</em></a> and <a href="https://www.omim.org/entry/300017" target="_blank"><em>FLNA</em></a></li> </ul> </td> </tr> <tr> <td class="indent1">Other forms of diffuse lung disease presenting in infancy</td> <td> <ul> <li>NEHI</li> <li>P.I.G.*</li> </ul> </td> </tr> <tr> <td class="indent1">Genetic disorders of surfactant dysfunction and related abnormalities</td> <td> <ul> <li>Mutations in the <a href="https://www.omim.org/entry/178640" target="_blank"><em>SFTPB</em></a>, <a href="https://www.omim.org/entry/178620" target="_blank"><em>SFTPC</em></a>, <a href="https://www.omim.org/entry/601615" target="_blank"><em>ABCA3</em></a>, <a href="https://www.omim.org/entry/600635" target="_blank"><em>NKX2-1</em></a>, and <em><a href="https://www.omim.org/entry/179514">RAB5B</a> </em>genes are associated with altered surfactant <span class="nowrap_whitespace">production<sup>¶</sup></span></li> <li>Mutations in the <a href="https://www.omim.org/entry/306250" target="_blank"><em>CSF2RA</em></a>, <a href="https://www.omim.org/entry/138981" target="_blank"><em>CSF2RB</em></a>, <a href="https://www.omim.org/entry/603593" target="_blank"><em>SLC7A7</em></a>, <a href="https://www.omim.org/entry/156560" target="_blank"><em>MARS1</em></a>, <a href="https://www.omim.org/entry/137295" target="_blank"><em>GATA2</em></a>, <a href="https://www.omim.org/entry/604260" target="_blank"><em>STAT5B</em></a>, and <a href="https://www.omim.org/entry/164350" target="_blank"><em>OAS1</em></a> genes impact the catabolism of surfactant via macrophage dysfunction; clinical manifestations may include pulmonary alveolar <span class="nowrap_whitespace">proteinosis<sup>Δ</sup></span></li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="2">Disorders not specific to infancy</td> </tr> <tr> <td class="indent1">Disorders of the normal host (immunocompetent)</td> <td> <ul> <li>Bronchiolitis obliterans – A clinical syndrome and histologic phenotype that may be caused by infectious (eg, adenovirus) or noninfectious processes (eg, toxic inhalation, chronic hypersensitivity pneumonitis, or connective tissue disease)</li> <li>Infectious/postinfectious processes – May cause chronic airway changes, bronchiolitis obliterans, or organizing pneumonia</li> <li>Related to environmental agents (toxic inhalation or hypersensitivity pneumonitis)</li> <li>Aspiration syndromes</li> <li>Idiopathic pulmonary hemosiderosis</li> <li>Other disorders (eosinophilic pneumonia, AIP, NSIP)</li> </ul> </td> </tr> <tr> <td class="indent1">Disorders of the immunocompromised host</td> <td> <ul> <li>Opportunistic infections</li> <li>Related to therapeutic intervention – eg, chemotherapy and/or radiation injury; drug reaction</li> <li>Related to transplantation or rejection syndromes (including bronchiolitis obliterans)</li> <li>Common histologic patterns include LIP and follicular bronchiolitis</li> </ul> </td> </tr> <tr> <td class="indent1">Disorders related to systemic disease processes</td> <td> <ul> <li>Immune-mediated <ul> <li>Anti-GBM antibody (Goodpasture); acquired pulmonary alveolar proteinosis/antibody to GM-CSF; pulmonary vasculitis syndromes</li> <li>Nonspecific pulmonary manifestations – NSIP, pulmonary hemorrhage syndromes, organizing pneumonia, nonspecific airway changes</li> <li>Collagen-vascular disease – eg, systemic lupus erythematosus, polymyositis/dermatomyositis, systemic sclerosis</li> </ul> </li> <li>Storage diseases</li> <li>Sarcoidosis</li> <li>Langerhans cell histiocytosis</li> <li>Malignant infiltrates</li> </ul> </td> </tr> <tr> <td class="indent1">Vascular disorders masquerading as ILD</td> <td> <ul> <li>Pulmonary hypertension</li> <li>Congestive vasculopathy and veno-occlusive disease</li> <li>Lymphatic disorders – eg, lymphangiectasia, lymphangiomatosis</li> <li>Pulmonary edema</li> <li>Thromboembolic disease</li> </ul> </td> </tr> <tr> <td class="indent1">Unclassified</td> <td> <ul> <li>Captures cases of diffuse lung disease that cannot be classified for any reason; common reasons include end-stage disease, nondiagnostic biopsies, or inadequate biopsy material</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>NEHI: neuroendocrine cell hyperplasia of infancy; P.I.G.: pulmonary interstitial glycogenosis; AIP: acute interstitial pneumonia; NSIP: nonspecific interstitial pneumonia; LIP: lymphocytic interstitial pneumonia; GBM: glomerular basement membrane; GM-CSF: granulocyte-macrophage colony-stimulating factor.</p>
<p>* Often occurs in conjunction with an alveolar growth abnormality.</p>
<p>¶ <em>NKX2-1</em> gene mutations may result in reduced expression of the genes responsible for surfactant production and metabolism. In addition, a spectrum of lung disease phenotypes, including abnormal lung development, has been reported in association with <em>NKX2-1</em>/<em>TTF1</em> gene mutations.</p>
Δ Refer to UpToDate content on genetic disorders of surfactant dysfunction and pulmonary alveolar proteinosis in children.</div><div class="graphic_reference">Adapted from:
<ol>
<li>Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: Application of a novel classification scheme. Am J Respir Crit Care Med 2007; 176:1120.</li>
<li>Fan LL, Dishop MK, Galambos C, et al. Diffuse Lung Disease in Biopsied Children 2 to 18 Years of Age. Application of the chILD Classification Scheme. Ann Am Thorac Soc 2015; 12:1498.</li>
</ol></div><div id="graphicVersion">Graphic 90987 Version 10.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
